User menu

Recombinant-human-erythropoietin for the Treatment of Anemia in the Myelodysplastic Syndromes - a Clinical and Erythrokinetic Assessment

Bibliographic reference Verhoef, GEG. ; Ferrant, Augustin ; Zachee, P. ; Demuynck, H. ; Selleslag, D. ; et. al. Recombinant-human-erythropoietin for the Treatment of Anemia in the Myelodysplastic Syndromes - a Clinical and Erythrokinetic Assessment. In: Annals of Hematology, Vol. 64, no. 1, p. 16-21 (1992)
Permanent URL http://hdl.handle.net/2078.1/50542
  1. Aoki I, Higashi K, Homori M, Chikazawa H, Ishikawa K (1990) Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome. Am J Hematol 35: 6–12
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., Proposals for the classification of the myelodysplastic syndromes, 10.1111/j.1365-2141.1982.tb08475.x
  3. Boogaerts MA, Nelissen V, Roelant C, Goossens W (1983) Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol 55: 217–227
  4. Bowen DT, Jacobs A, Mary P, Cotes, Lewis TC (1990) Serum erythropoietin and erythropoiesis in patients with myelodys-plastic syndromes. Eur J Haematol 44: 30–32
  5. Bowen D, Culligan D, Jacobs A (1991) The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br J Haematol 77: 419–423
  6. Dessypris EN, Krantz SB (1984) Effect of pure erythropoietin on DNA-synthesis by human marrow day-15 erythroid burst-forming units in short-term liquid culture. Br J Haematol 56: 295–306
  7. Dessypris EN, Gleaton JH, Armstrong OL (1987) Effect of human recombinant erythropoietin on human marrow mega-karyocyte colony formation in vitro. Br J Haematol 65: 265–269
  8. Dessypris EN, Graber SE, Krantz SB, Stone WJ (1988) Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 72: 2060–2062
  9. Dormer P, Hershko C, Wilmanns W (1987) Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromes. Br J Haematol 67: 147–152
  10. Egrie JC, Cotes PM, Lane J, Gaines Das RE, Tan RC (1987) Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods 99: 235–241
  11. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase-I and -II clinical trial. N Engl J Med 316: 73–78
  12. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA (1990) Recombinant human erythro-poietin for patients with AIDS treated with Zidovudine. N Engl J Med 322: 1488–1493
  13. Galton DAG (1986) The myelodysplastic syndromes. Scand J Haematol 36 [Suppl 45]: 11–20
  14. Geissler K, Stockenhuber F, Kabrna E, Hinterberger W, Balcke P, Lechner K (1989) Recombinant human erythropoietin and haematopoietic progenitor cells in vivo. Blood 73: 2229
  15. Gregory CJ, Eaves AC (1977) Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood 49: 855–864
  16. Hirashima K, Bessho M, Susaki L, Miyazawa K, Nagashima M (1989) Improvement of anaemia by intravenous injection of recombinant erythropoietin in patients with myelodysplastic syndrome and aplastic anaemia. Exp Haematol 17: 385
  17. International Committee for Standardization in Haematology (1971) Recommended methods for radioisotope red cell survival. Blood 38: 378–386
  18. Jacobs A (1985) Myelodysplastic syndromes: pathogenesis, functional abnormalities and clinical implications. J Clin Pathol 38: 1201–1217
  19. Jacobs A, Janowska-Wieczorek A, Caro J, Bowen DT, Lewis T (1989) Circulating erythropoietin in patients with myelodys-plastic syndromes. Br J Haematol 73: 36–39
  20. Kannourakis G, Johnson GR (1988) Fractionation of subsets of BFU-E from normal human bone marrow: responsiveness to erythropoietin, human placental-conditioned medium, or granulocyte macrophage colony-stimulating factor. Blood 71: 758–765
  21. Ludwig H, Fritz E, Kotzmann H, Höcker P, Gisslinger H, Barnas U (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322: 1693–1699
  22. Means RT, Olsen NJ, Krantz SB, Dessypris EN, Graber SE, Stone WJ, O'Neil VL, Pincus T (1989) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 32: 638–642
  23. Mitjavila MT, Villeval JL, Cramer P, Henri A, Gasson J, Krystal G, Tulliez M, Berger R, Breton-Gorius J, Vainchenker W (1987) Effects of granulocyte-macrophage colony-stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemias. Blood 70: 965–973
  24. Motoji T, Hoshino S, Ueda M, Takanashi M, Masuda M, Nakayama K, Oshimi K, Mizoguchi H (1990) Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietin. Br J Haematol 75: 60–67
  25. Nishi N, Nakahata T, Koike K, Takagi M, Nagunuma K, Aka-bane T (1990) Induction of mixed erythroid-megakaryocyte colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture. Blood 76: 1330–1335
  26. Ohyashiki K, Fujieda H, Iwabuchi A, Ohyashiki JH, Toyama K (1990) In vitro cytogenetic effects of recombinant human hematopoietic growth factors on cells derived from myelodys-plastic syndromes. Cancer Genet Cytogenet 48: 169–178
  27. Oster W, Herrmann F, Gamm H, Zeile G, Lindemann A, Muller G, Brune T, Kraemer H, Mertelsmann R (1990) Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J Clin Oncol 8: 956–962
  28. Ricketts C, Jacobs A, Cavill I (1975) Ferrokinetics and erythropoiesis in man: the measurement of effective erythropoiesis, ineffective erythropoiesis and red cell life span using59Fe. Br J Haematol 31: 65–75
  29. Roodman GD, Bird A, Hutzler D, Montgomery W (1987) Tumor necrosis factor-alpha and haematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the haematopoietic cell lines K 562, HL 60, and HEL cells. Exp Haematol 15: 928
  30. Schouten HC, Vellenga E, van Rhenen DJ, de Wolf DJ, Coppens PJW, Blijham GH (1991) Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 5: 432–436
  31. Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B (1990) High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study. Exp Haematol 18: 1204–1208
  32. Urabe A, Kitamura T, Takaku F (1988) Clinical application of erythropoietin. Acta Haematol (Japonica) 51: 1355–1359
  33. Vadhan-Raj S, Hittelman WN, Lepe-Zuniga JL, Gutterman JU, Broxmeyer HE (1990) Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes. N Engl J Med 75: 1749–1750
  34. Verhoef G, De Wolf-Peeters C, Kerim S, Van De Broeck J, Mecucci C, Van Den Berghe H, Boogaerts M (1991) Update on the prognostic implication of morphology, histology and karyotype in primary myelodysplastic syndromes. Hematol Pathol 5: 163–175
  35. Witte T, Zwaan F, Hermans J, Vernant J, Kolb H, Vossen J, Lönqvist B, Beelen D, Ferrant A, Gmur J, Liu Yin J, Troussard X, Cahn J, Van Lint M, Gratwohl A (1990) Allogeneic bone marrow transplantation for secondary leukaemia and myelo-dysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 74: 151–155
  36. Zoumbos N, Symeonidis A, Kourakli A, Katevas P, Matsouka P, Perraki M, Geogoulias V (1991) Increased levels of soluble interleukin-2 receptors and tumor necrosis factor in serum of patients with myelodysplastic syndromes. Blood 77: 413–414